Biweekly docetaxel-cisplatin in chemonaïve patients with squamous NSCLC
14th World Conference on Lung Cancer 2011
Biweekly docetaxel-cisplatin in chemonaïve patients with squamous NSCLC Leer más »
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.
Cancer Chemother Pharmacol. 2009 Jul;64(2):379-84. Rubio JC1, Vázquez S, Vázquez F, Amenedo M, Fírvida JL, Mel JR, Huidobro G, Alvarez E, Lázaro
Rubio JC1 et al.
Ver
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).
Anticancer Drugs. 2007 Nov;18(10):1201-6. Vázquez S1, Huidobro G, Amenedo M, Fírvida JL, León L, Lázaro M, Grande C, Mel JR, Ramos M,
Vázquez S1 et al.
Ver
Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
Anticancer Drugs. 2004 Jun;15(5):489-94. Vázquez S1, Grande C, Amenedo M, Fírvida JL, Lázaro M, Alonso G, Curiel T, Huidobro G, Mel JR,
Vázquez S1 et al.
Ver
Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
Lung Cancer. 2003 May;40(2):215-20. León L1, Cueva-Banuelos JF, Huidobro G, Fírvida JL, Amenedo M, Lázaro M, Romero C, Estévez SV, Barón FJ,
León L1 et al.
Ver
